|
US4659715A
(en)
|
1986-03-07 |
1987-04-21 |
Louisiana State University And Agricultural And Mechanical College |
Method of inhibiting body fat stores
|
|
US4783469A
(en)
|
1986-03-07 |
1988-11-08 |
Meier Albert H |
Method of inhibiting body fat stores
|
|
US4791125A
(en)
|
1987-12-02 |
1988-12-13 |
Pfizer Inc. |
Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
|
|
US5468755A
(en)
|
1988-05-10 |
1995-11-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Therapeutic process for the treatment of the pathologies of Type II diabetes
|
|
US5744477A
(en)
|
1988-05-10 |
1998-04-28 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Method for treatment of obesity using prolactin modulators and diet
|
|
US5830895A
(en)
|
1988-05-10 |
1998-11-03 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Methods for the determination and adjustment of prolactin daily rhythms
|
|
US6004972A
(en)
|
1988-05-10 |
1999-12-21 |
The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College |
Therapeutic process for the treatment of the pathologies of type II diabetes
|
|
US5716932A
(en)
|
1988-05-10 |
1998-02-10 |
Louisiana State University And Agricultural And Mechanical College |
Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
|
|
US5700800A
(en)
|
1988-05-10 |
1997-12-23 |
Ergo Science Incorporated |
Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
|
|
US5344832A
(en)
|
1990-01-10 |
1994-09-06 |
The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College |
Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
|
|
US5668155A
(en)
|
1988-05-10 |
1997-09-16 |
The General Hospital Corporation |
Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
|
|
US5585347A
(en)
|
1988-05-10 |
1996-12-17 |
Ergo Science Incorporated |
Methods for the determination and adjustment of prolactin daily rhythms
|
|
US5006526A
(en)
|
1988-10-17 |
1991-04-09 |
Louisiana State University |
Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
|
|
IT1235053B
(it)
*
|
1989-04-07 |
1992-06-17 |
Poli Ind Chimica Spa |
Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
|
|
CA2030174C
(en)
|
1990-01-10 |
1996-12-24 |
Anthony H. Cincotta |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
|
|
US5696128A
(en)
|
1994-07-07 |
1997-12-09 |
The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College |
Method of regulating immune function
|
|
IL112106A0
(en)
*
|
1993-12-22 |
1995-03-15 |
Ergo Science Inc |
Accelerated release composition containing bromocriptine
|
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
US5565454A
(en)
|
1995-05-31 |
1996-10-15 |
Ergo Science, Incorporated |
Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
|
|
US5792748A
(en)
|
1995-06-07 |
1998-08-11 |
The General Hospital Corporation |
Method for inhibiting neoplastic disease in mammals
|
|
US5626860A
(en)
|
1995-06-07 |
1997-05-06 |
The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College |
Method for regulating metabolism with dopamine beta hydroxylase inhibitors
|
|
US5714519A
(en)
|
1995-06-07 |
1998-02-03 |
Ergo Science Incorporated |
Method for regulating glucose metabolism
|
|
US20010016582A1
(en)
|
1997-04-28 |
2001-08-23 |
Anthony H. Cincotta |
Method and composition for the treatment of lipid and glucose metabolism disorders
|
|
US5877183A
(en)
|
1996-06-06 |
1999-03-02 |
Ergo Research Corporation |
Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists
|
|
US9655865B2
(en)
|
2002-07-29 |
2017-05-23 |
Veroscience, Llc |
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
|
|
US20040220190A1
(en)
|
2002-07-29 |
2004-11-04 |
Cincotta Anthony H. |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20080200453A1
(en)
|
2002-07-29 |
2008-08-21 |
Cincotta Anthony H |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20040077679A1
(en)
|
2002-07-29 |
2004-04-22 |
Cincotta Anthony H. |
Therapeutic treatment for the metabolic syndrome and type 2 diabetes
|
|
US20050054652A1
(en)
|
2002-07-29 |
2005-03-10 |
Cincotta Anthony H. |
Methods of treating metabolic syndrome using dopamine receptor agonists
|
|
US20040081678A1
(en)
|
2002-08-09 |
2004-04-29 |
Anthony Cincotta |
Therapeutic process for the treatment of obesity and associated metabolic disorders
|
|
US8821915B2
(en)
|
2002-08-09 |
2014-09-02 |
Veroscience, Llc |
Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
|
|
JP4931349B2
(ja)
|
2003-01-23 |
2012-05-16 |
エスペリオン セラピューティクス，インコーポレイテッド |
コレステロール管理およびそれに関連した使用に供するヒドロキシル化合物および組成物
|
|
US7655692B2
(en)
*
|
2003-06-12 |
2010-02-02 |
Pfizer Inc. |
Process for forming amorphous atorvastatin
|
|
US8137993B2
(en)
|
2004-03-25 |
2012-03-20 |
Veroscience Llc |
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
US20050215558A1
(en)
|
2004-03-25 |
2005-09-29 |
Cincotta Anthony H |
Methods of identifying responders to dopamine agonist therapy
|
|
US8137994B2
(en)
|
2004-03-25 |
2012-03-20 |
Veroscience Llc |
Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof
|
|
EA011379B1
(ru)
|
2005-03-04 |
2009-02-27 |
Никомед Фарма Ас |
Способ получения кальциевых композиций в непрерывном псевдоожиженном слое
|
|
JP5543110B2
(ja)
*
|
2006-01-05 |
2014-07-09 |
エッセンシャリス，インク． |
カリウムａｔｐチャネルオープナの塩およびその使用
|
|
WO2007119792A1
(ja)
*
|
2006-04-13 |
2007-10-25 |
Toa Pharmaceuticals Co., Ltd. |
乾式直打速崩壊性錠剤
|
|
EP2146696B1
(en)
|
2007-04-13 |
2020-01-22 |
Dow Global Technologies LLC |
Granular material for dosage forms
|
|
US20210401824A1
(en)
|
2007-06-21 |
2021-12-30 |
Veroscience Llc |
Parenteral Formulations of Dopamine Agonists
|
|
US20100035886A1
(en)
|
2007-06-21 |
2010-02-11 |
Veroscience, Llc |
Parenteral formulations of dopamine agonists
|
|
EP2217073B1
(en)
|
2007-06-21 |
2019-10-09 |
VeroScience LLC |
Method of treating metabolic disorders and depression with dopamine receptor agonists
|
|
US8741918B2
(en)
*
|
2007-06-21 |
2014-06-03 |
Veroscience Llc |
Parenteral formulations of dopamine agonists
|
|
US7631155B1
(en)
|
2007-06-30 |
2009-12-08 |
Emc Corporation |
Thin provisioning of a file system and an iSCSI LUN through a common mechanism
|
|
JP2011500557A
(ja)
*
|
2007-10-11 |
2011-01-06 |
マゼンス インコーポレイテッド |
ナフトキノン系化合物の微粒化粒子を含有する医薬組成物
|
|
AU2010256366B2
(en)
|
2009-06-05 |
2014-08-21 |
Veroscience, Llc |
Combination of dopamine agonists plus first phase insulin secretagouges for the treatment of metabolic disorders
|
|
US9352025B2
(en)
|
2009-06-05 |
2016-05-31 |
Veroscience Llc |
Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
|
|
EP2579876A4
(en)
|
2010-06-08 |
2013-11-27 |
Veroscience Llc |
THERAPEUTIC TREATMENT OF METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR PREDICT
|
|
EP2646032A4
(en)
|
2010-11-23 |
2014-04-30 |
Veroscience Llc |
THERAPEUTIC TREATMENT OF METABOLIC SYNDROME AND TYPE 2 DIABETES, ADIPOSITAS OR PREDICTES
|
|
US8431155B1
(en)
|
2012-04-30 |
2013-04-30 |
Veroscience Llc |
Bromocriptine formulations
|
|
CA2915405A1
(en)
|
2013-06-13 |
2014-12-18 |
Veroscience Llc |
Compositions and methods for treating metabolic disorders
|
|
EP3925610A1
(en)
|
2016-04-20 |
2021-12-22 |
VeroScience LLC |
Composition and method for treating metabolic disorders
|
|
US20170340271A1
(en)
|
2016-05-26 |
2017-11-30 |
Veroscience Llc |
Methods for identifying responders to dopaminergic neuronal enhancing therapies for the treatment of elevated heart rate and metabolic or cardiovascular conditions
|
|
HRP20241365T1
(hr)
|
2017-10-18 |
2024-12-20 |
Veroscience Llc |
Poboljšane formulacije bromokriptina
|
|
US11607455B2
(en)
|
2019-09-23 |
2023-03-21 |
Veroscience Llc |
Method for inducing tumor regression
|